BIVI
BioVie Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.41
+0.02 ▲ +1.44%
🌙 3월 13일 7:48 PM ET (한국 3/14 08:48)
$1.45
+0.04 ▲ +2.84%
| Index | - | P/E | - | EPS (ttm) | -5.08 | Insider Own | 4.75% | Shs Outstand | 0.01B | Perf Week | 3.68% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | 22.61% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 17.41% | Short Float | 1.97% | Perf Quarter | -10.76% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | 1.46% | Short Ratio | 1.32 | Perf Half Y | -25% |
| Sales | 0.00B | P/B | 0.55 | EPS next 5Y | - | ROA | -72.35% | Short Interest | 0.14M | Perf YTD | 21.55% |
| Book/sh | 2.55 | P/C | 0.52 | EPS past 3/5Y | 51.42% 55.38% | ROE | -80.74% | 52W High | -89.32% ($13.20) | Perf Year | -86.18% |
| Cash/sh | 2.72 | P/FCF | - | Sales past 3/5Y | - | ROIC | -89.64% | 52W Low | 33.02% ($1.06) | Perf 3Y | -99.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 87.15% | Gross Margin | - | Volatility(W/M) | 6.39% 8.36% | Perf 5Y | -99.93% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.1 | Perf 10Y | -99.89% |
| Dividend Ex-Date | - | Quick Ratio | 7.25 | EPS Q/Q | 83.17% | Profit Margin | - | RSI (14) | 58.42 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.25 | Sales Q/Q | - | SMA20 | 5.9% ($1.33) | Beta | 0.59 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2025/12/03 | SMA50 | 11.56% ($1.26) | Rel Volume | 0.46 | Prev Close | $1.39 |
| Employees | 13 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -57.9% ($3.35) | Avg Volume(3M) | 0.11M | Price | $1.41 |
| IPO | 2014/5/5 | Option/Short | No/Yes | Trades | 259 | Volume | 49,864 | Change | 1.44% |
뉴스 로딩 중...